The Beers Criteria: A Practical Guide to Safe Medications for Seniors

Imagine you are caring for a parent or grandparent who takes six different pills every day. You want them to feel better, but have you ever wondered if one of those pills is actually making things worse? For older adults, the body changes in ways that affect how drugs work. Kidneys filter slower, livers process chemicals differently, and the brain becomes more sensitive to side effects like confusion or dizziness. This is where the Beers Criteria comes in.

The Beers Criteria is not just a list of "bad" drugs. It is a vital clinical guideline created by the American Geriatrics Society (AGS) to help doctors and pharmacists identify medications that pose more risks than benefits for people aged 65 and older. Think of it as a safety net. Its goal is simple: prevent falls, avoid hospitalizations, and keep seniors living independently for longer.

What Exactly Is the Beers Criteria?

To understand the tool, we need to look at its roots. The criteria were first developed by Dr. Mark Beers in 1991. Back then, it was a modest list of medications to avoid in nursing homes. Today, it is the gold standard for geriatric medication safety in the United States. The AGS formally adopted it in 2011 and updates it every three years based on fresh research.

The most recent update, published in May 2023, involved an expert panel reviewing over 7,300 high-quality studies. They added 32 new medications to the watchlist and removed 18 others because new evidence showed they were safer than previously thought. This rigorous process ensures the guidelines reflect current medical science, not outdated assumptions.

Why does this matter now? Because seniors make up about 13.5% of the U.S. population but use 34% of all prescription medications. According to data from the Centers for Disease Control and Prevention (CDC), potentially inappropriate medication use affects roughly 23% of community-dwelling older adults. That means nearly one in four seniors is taking a drug that could be harming them. Even scarier, these medications contribute to 15% of all hospital admissions among seniors. Many of these trips to the ER could have been prevented with better prescribing practices.

How the Beers Criteria Works: Five Key Sections

The 2023 Beers Criteria isn't a single long list. It is organized into five distinct sections to guide healthcare providers through complex decisions. Understanding these categories helps patients and caregivers ask smarter questions during doctor visits.

1. Medications Generally Inappropriate: These are drugs that should almost never be used in older adults because the risks outweigh the benefits. A prime example is first-generation antihistamines like diphenhydramine (often found in sleep aids). They cause strong anticholinergic effects, leading to dry mouth, constipation, and significant confusion. The 2023 criteria give these a "strong recommendation" for avoidance.
2. Medications Inappropriate Due to Specific Conditions: Some drugs are fine for young people but dangerous for seniors with certain health issues. For instance, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can worsen heart failure or kidney disease. If a senior has heart failure, NSAIDs are flagged as inappropriate.
3. Medications Requiring Caution: These drugs might be necessary but require close monitoring or dose adjustments. Anticoagulants like dabigatran fall here. For adults over 75 or those with poor kidney function, the risk of gastrointestinal bleeding is higher compared to other options like warfarin. Doctors must weigh the benefits carefully.
4. Harmful Drug-Drug Interactions: Taking two safe drugs together can create a dangerous mix. Combining anticholinergic medications with opioids, for example, drastically increases the risk of severe constipation and cognitive impairment. The criteria highlight these specific pairings to avoid.
5. Dose Adjustments for Renal Impairment: As kidneys age, they filter waste less efficiently. Drugs like gabapentin need lower doses when creatinine clearance drops below 60 mL/min. The Beers Criteria provides specific thresholds to guide these adjustments.

Common Medications to Watch Out For

You don't need to memorize the entire list, but knowing a few common culprits can spark important conversations with your healthcare provider. Here are some frequent offenders identified by the Beers Criteria:

• Benzodiazepines: Often prescribed for anxiety or insomnia (e.g., lorazepam, diazepam). In seniors, these increase the risk of falls, fractures, and delirium. Long-term use is strongly discouraged.
• Antipsychotics: Used for dementia-related psychosis, these carry a black box warning for increased mortality in elderly patients with dementia. They should only be used in extreme cases after non-drug therapies fail.
• First-Generation Antihistamines: Diphenhydramine and hydroxyzine cause sedation and confusion. Newer alternatives or non-drug approaches are preferred for allergies or sleep.
• Skeletal Muscle Relaxants: Drugs like cyclobenzaprine have strong anticholinergic effects, similar to old-school allergy meds, leading to dry mouth, blurred vision, and urinary retention.

Beers Criteria vs. STOPP/START: Which Is Better?

If you dig into medication safety tools, you will likely encounter another name: STOPP/START criteria. Developed in Europe, this tool focuses on screening for both potentially inappropriate prescriptions (STOPP) and potential prescribing omissions (START). So, which one should you trust?

In the United States, the Beers Criteria dominates. About 87% of U.S. healthcare systems have integrated it into their electronic health records (EHRs). This is partly because it aligns well with Medicare Part D regulations, which mandate medication therapy management reviews using the Beers Criteria for beneficiaries taking eight or more medications.

However, each tool has strengths. The Beers Criteria is excellent for identifying individual risky drugs. But critics, including some experts at Harvard Medical School, note that it doesn't always account for socioeconomic factors. For example, a cheaper medication might be on the Beers List, but if a senior cannot afford the safer alternative, the doctor faces a tough choice. The STOPP/START criteria, widely used in Europe, offers a more condition-specific approach, looking at the whole clinical picture rather than just the drug list. Ideally, clinicians use both perspectives to get the full story.

Challenges in Real-World Use

Even the best guidelines face hurdles when applied in busy clinics. One major issue is "alert fatigue." When EHR systems like Epic generate a dozen Beers Criteria alerts per patient visit, doctors may start ignoring them. A survey of primary care physicians on Medscape revealed that 32% reported frustration with excessive alerts, making it hard to prioritize truly dangerous interactions.

Another challenge is palliative care. In end-of-life scenarios, the goal shifts from longevity to comfort. A drug that is "inappropriate" for a healthy senior might be essential for managing severe pain or agitation in a hospice patient. The Beers Criteria acknowledges this, but applying it requires nuanced judgment that automated systems often miss.

There is also a communication gap. According to the National Council on Aging, 61% of seniors surveyed were unaware their medications were being evaluated against safety criteria like the Beers List. Patients often assume that if a doctor prescribed it, it must be perfect. Educating seniors to review their meds annually can bridge this gap.

How to Protect Your Loved Ones

You don't need to be a pharmacist to use the Beers Criteria effectively. Here are practical steps to ensure medication safety for older adults:

• Bring a Brown Bag: Once a year, bring all medications-including over-the-counter drugs, vitamins, and herbal supplements-to the doctor's office. Ask specifically: "Are any of these on the Beers Criteria list?"
• Ask About Non-Drug Options: If a senior is prescribed a benzodiazepine for sleep, ask if Cognitive Behavioral Therapy for Insomnia (CBT-I) or melatonin could work instead. The 2023 update includes an "Alternatives List" to guide these choices.
• Monitor for Side Effects: Watch for signs of anticholinergic burden: dry mouth, constipation, urinary retention, blurred vision, and memory problems. If these appear, contact the doctor immediately.
• Check Kidney Function: Ensure the doctor regularly checks creatinine clearance levels. Dosages for many drugs need adjustment as kidney function declines.
• Use Technology: The AGS offers a free mobile app with quarterly updates. Pharmacists and caregivers can use it to quickly check if a medication is flagged.

The Future of Senior Medication Safety

The landscape of geriatric care is evolving. The American Geriatrics Society recently released a companion document detailing 147 evidence-based alternatives to Beers-listed medications. This shift from "what to avoid" to "what to do instead" marks a significant step forward.

Looking ahead, artificial intelligence is set to play a bigger role. The AGS is partnering with Google Health AI to develop predictive analytics that identify patients at highest risk before adverse events occur. By 2026, the next update of the Beers Criteria will expand renal dosing guidance to cover 100% of medications eliminated by the kidneys, closing a critical gap in current recommendations.

While challenges remain, especially in resource-limited settings where affordable alternatives are scarce, the Beers Criteria remains the most widely adopted tool globally. Translated into 17 languages and used in 28 countries, it continues to save lives by keeping seniors out of hospitals and helping them age with dignity.